Integral Derivatives’s Boston Scientific BSX Stock Holding History

Integral Derivatives’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-61,600	Closed	-$809K	–	1316
2013 Q4	$740K	Buy	+61,600	New	+$728K	0.01%	906

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Integral Derivatives's BSX Position: Q1 2014 in Review

Integral Derivatives sold out of Boston Scientific (BSX) in Q1 2014, closing a stake of 61,600 shares — an estimated $809K sold.

Integral Derivatives first reported a position in BSX in Q4 2013 and held it in 1 quarter. The position peaked at $740K in Q4 2013. 440 funds tracked by Wall St. Rank hold BSX as of Q1 2014.

Integral Derivatives reported no remaining Boston Scientific position as of Q1 2014 after selling out during the quarter.
Integral Derivatives sold 61,600 Boston Scientific shares in Q1 2014, an estimated $809K.
Integral Derivatives first reported a position in Boston Scientific in Q4 2013 and held it in 1 quarter.
Integral Derivatives's Boston Scientific position peaked at $740K in Q4 2013.
440 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2014.

Based on Integral Derivatives's 13F filing for Q1 2014, filed 2 May 2014.